Ono Pharmaceutical Co. is a Japanese company that operates in the specialty pharma sector. The company was founded in 1717 and has since then been dedicated to providing innovative and high-quality pharmaceutical products to patients worldwide. Ono Pharmaceutical Co. has a strong focus on research and development, and the company's mission is to contribute to society through the creation of new drugs that improve the quality of life for patients.

As a responsible corporate citizen, Ono Pharmaceutical Co. is committed to reducing its carbon footprint and promoting decarbonisation. The company recognises that climate change is one of the most pressing challenges facing the world today, and it is taking steps to reduce its impact on the environment. Ono Pharmaceutical Co. has set ambitious targets to reduce its greenhouse gas emissions, and it is working to achieve these targets through a range of initiatives.

One of the key initiatives that Ono Pharmaceutical Co. has implemented is the use of renewable energy. The company has invested in solar panels and wind turbines to generate clean energy, and it is actively seeking to increase its use of renewable energy sources. Ono Pharmaceutical Co. recognises that renewable energy is essential to achieving decarbonisation, and the company is committed to playing its part in the transition to a low-carbon economy.

In addition to investing in renewable energy, Ono Pharmaceutical Co. is also implementing a corporate energy strategy to reduce its overall energy consumption. The company is working to improve the energy efficiency of its facilities and processes, and it is exploring new technologies and practices to reduce its energy use. Ono Pharmaceutical Co. recognises that reducing energy consumption is an important part of its decarbonisation efforts, and it is committed to achieving significant reductions in its energy use over the coming years.

Another important initiative that Ono Pharmaceutical Co. has implemented is the use of corporate power purchase agreements (PPAs). PPAs allow companies to purchase renewable energy directly from energy providers, and they are an effective way to increase the use of renewable energy. Ono Pharmaceutical Co. has signed several PPAs with renewable energy providers, and these agreements have helped the company to increase its use of clean energy. By using PPAs, Ono Pharmaceutical Co. is demonstrating its commitment to decarbonisation and its support for the renewable energy industry.

Overall, Ono Pharmaceutical Co. is a company that is committed to sustainability and decarbonisation. The company recognises that climate change is a major challenge facing the world today, and it is taking action to reduce its impact on the environment. By investing in renewable energy, implementing a corporate energy strategy, and using PPAs, Ono Pharmaceutical Co. is demonstrating its commitment to sustainability and its role as a responsible corporate citizen. The company's focus on research and development, combined with its commitment to sustainability, makes it a leader in the specialty pharma sector and a model for other companies to follow.